Tessa Therapeutics

Tessa Therapeutics Pte Ltd. is a biotechnology company based in Singapore, established in 2011. The company specializes in developing cancer immunotherapies, focusing on T cell therapy for solid tumors. Tessa Therapeutics is known for its innovative approaches, including the development of virus-specific T cells and CAR T cells, aimed at treating lymphoma. Through its advancements in cell therapy, the company seeks to enhance treatment options for cancer patients and improve their overall quality of life.

Malcolm Brenner

Founder

1 past transactions

Euchloe Bio

Acquisition in 2017
Euchloe Bio specializes in the discovery, development, engineering and commercialization of novel, fully-human antibodies for the treatment of cancer, using its proprietary antibody engineering technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.